CQ fluency Appoints Tameeka Smith as Chief Executive Officer
Tenured healthcare executive to succeed Founder
Smith to build on 25-year legacy of language access and cultural intelligence
Smith is a dynamic healthcare leader with a proven track record and extensive experience advancing managed care and championing health equity. Most recently, as CEO of UnitedHealthcare Community Plan of
This transition marks a strategic evolution for CQ fluency as it enters its next chapter of growth and impact. "I am honored to step into the role of CEO at CQ fluency, a company whose mission aligns so closely with my own purpose and professional journey," said Smith. "What drew me to CQ is its unwavering belief that care begins with communication—and that language and culture should never be barriers to connection or compassion." Smith continued "I deeply admire the foundation that Elisabete built and the values-driven culture that has powered CQ's growth. As we look to the future, my focus is on expanding our impact through thoughtful growth and innovation—always putting people first."
Ms.
Under Smith's leadership, CQ fluency will strengthen its market position by building on its foundation in culturally relevant translation and accessibility services, expanding its reach through innovation, and continuing its mission to ensure equitable access to care and services for everyone.
About CQ fluency
CQ fluency delivers culturally relevant translation and accessibility solutions powered by advanced technology and human expertise to help healthcare, life sciences, and other regulated industries effectively communicate with multilingual audiences, improve health equity, and streamline global operations. CQ fluency is a portfolio company of Ariel Alternatives, LLC, a private investment firm affiliated with Ariel Investments, LLC.
More about CQ fluency can be found on our website at www.CQfluency.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cq-fluency-appoints-tameeka-smith-as-chief-executive-officer-302485739.html
SOURCE CQ fluency
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Americans for Safe and Effective Medicines Launches to Protect Patients from Illegal Mass Compounding, Counterfeit Drugs, and Misleading Marketing
- Newronika Receives CE Mark for αDBS®, Advancing Its Mission to Make Adaptive Therapy the Standard of Care
- M&A Source® Shares Highlights from the 2026 Spring Conference and Deal Market
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share